| Name | Title | Contact Details |
|---|
Dailys Meats is a food and beverage manufacturing company that specializes in bacon, ham, and sausage.
Founded in 1983, ingredients PLUS is a technology driven food ingredient processor and distributor with an elite fleet of company owned logistics capabilities. Headquartered in Rochester, NY, with manufacturing and distribution operations located in Lakeville, NY and Landisville, PA, Ingredients PLUS prioritizes its mission of providing outstanding customer care each day, every day, in everything we do. With over 3 miles of company owned short-line railroad, 200+ company owned fleet assets, logistics technology and geospatial analytics, and manufacturing, processing, and distribution operations in the Northeast and Mid-Atlantic, ingredients PLUS controls essential elements of the supply chain to ensure quality ingredients are delivered precisely WHEN the customer needs them. Our values of Commitment, Innovation, Passion, Boldness, and People & Community show in the way our team goes the extra mile to serve our customers and our community. Ingredients PLUS, it`s “All About the WHEN”!
We believe a just food system begins with breakfast. So we`re searching faster and further, working with rural farmers, Michelin-starred chefs and world-class product developers to find tools in the plant kingdom that will make our food tastier, healthier, and more sustainable.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.